Riskpilot← Back to searchSign inGet full accessNERVE CONSULTING AB
ABActiveOrg 5590157763Birger Jarlsgatan 18 No 18Business and other management consultancy activities · NACE 7020Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
-11940.0%
Financial strength
Net profit 2024
SEK 3
+50% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 3 | +50% |
| Total assets | SEK 7K | +0% |
| Equity | SEK -778K | +0% |
| Employees | 0 | — |
Legal name
NERVE CONSULTING AB
Org number
5590157763
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
1 juni 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva konsultverksamhet med inriktning på strategi, management och affärsutveckling och därmed förenlig verksamhet.
Address
Birger Jarlsgatan 18 No 18
Email
per.anell@tij.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | 0 | 0 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | −16 | −5 | 0 | — | — |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −16 | −5 | 0 | 0 | 0 |
| Net financials | −2 | −3 | −0 | 0 | 0 |
| Profit before tax | −18 | −9 | −0 | 0 | 0 |
| Tax | −0 | −0 | — | — | — |
| Net profit | −18 | −9 | −0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 | 7 | 7 | 7 | 7 |
| Equity | −769 | −778 | −778 | −778 | −778 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 778 | 785 | 785 | 785 | 785 |
| Total debt | 778 | 785 | 785 | 785 | 785 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
-11940.0%
This company
38.2%
Market median
-31357% vs market
20202024
Return on equity
300.0%
This company
18.4%
Market median
+1530% vs market
20202024
Net profit margin
300.0%
This company
8.1%
Market median
+3604% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.01×
This company
0.62×
Market median
-63% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PI Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bläckhall Invest AB
NERVE CONSULTING AB Board members of NERVE CONSULTING AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Ingemar Anell | Chief Executive Officer | 0 companies |
| Johanna Christina Stridsman | Chairman | 0 companies |
| Björn Johan Strömberg | Deputy Board Member | 0 companies |